Regaining Function After Spinal Cord Injury: A New Path Forward? Dr. Adam Rogers, CEO, NervGen Pharma
About this episode
Dr. Moira Gunn interviews Dr. Adam Rogers about a promising new treatment for spinal cord injuries showing significant results in trials.
On this week’s BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that’s showing significant trial results for patients with spinal cord injuries. While typically, patient progress is defined by the early months of recovery after the injury, some trial participants have seen increased function as much as 10 years post-trauma.
More episodes of BioTech Nation ... with Dr. Moira Gunn
- 50 Years of Genentech...Ashley Magargee, CEO, Genentech
- New treatment being tested for pre-term babies... Dr. Marc Salzberg, CEO and Chief Medical Officer, Airway Therapeutics
- Now, Near, Next...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
- Changing the Future of Cancer Surgery...A 2017 Interview with Dr. Phil Low, Professor & Biotech Entrepreneur
- Who is Medically Qualified to Go to Space??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
- Big Tech & Healthcare...Dr. Marschall Runge, Author, "The Great Healthcare Disruption"
Explore listener stats, chart rankings, contacts and more on the BioTech Nation ... with Dr. Moira Gunn podcast page.